Cadent
Novartis acquires Cadent Therapeutics in potential $770 million deal
December 17, 2020Sales and Marketing Cadent, Novartis, acquisition
Novartis has sealed an agreement with Cadent Therapeutics to acquire the firm in a deal worth up to $770 million, …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
